Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP175329.RAvYVE1CgLJj3frgpI4woLKv6biqIoc-g3brRYVrwZiLA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP175329.RAvYVE1CgLJj3frgpI4woLKv6biqIoc-g3brRYVrwZiLA130_assertion type Assertion NP175329.RAvYVE1CgLJj3frgpI4woLKv6biqIoc-g3brRYVrwZiLA130_head.
- NP175329.RAvYVE1CgLJj3frgpI4woLKv6biqIoc-g3brRYVrwZiLA130_assertion wasGeneratedBy ECO_0000203 NP175329.RAvYVE1CgLJj3frgpI4woLKv6biqIoc-g3brRYVrwZiLA130_provenance.
- NP175329.RAvYVE1CgLJj3frgpI4woLKv6biqIoc-g3brRYVrwZiLA130_assertion wasDerivedFrom lhgdn-20090331 NP175329.RAvYVE1CgLJj3frgpI4woLKv6biqIoc-g3brRYVrwZiLA130_provenance.
- NP175329.RAvYVE1CgLJj3frgpI4woLKv6biqIoc-g3brRYVrwZiLA130_assertion SIO_000772 14710368 NP175329.RAvYVE1CgLJj3frgpI4woLKv6biqIoc-g3brRYVrwZiLA130_provenance.
- NP175329.RAvYVE1CgLJj3frgpI4woLKv6biqIoc-g3brRYVrwZiLA130_assertion evidence source_evidence_literature NP175329.RAvYVE1CgLJj3frgpI4woLKv6biqIoc-g3brRYVrwZiLA130_provenance.
- NP175329.RAvYVE1CgLJj3frgpI4woLKv6biqIoc-g3brRYVrwZiLA130_assertion description "[Ability of a monoclonal antibody to down-regulate the receptor may be an important antibody property in targeting the insulin-like growth factor-I receptor for the treatment of certain cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP175329.RAvYVE1CgLJj3frgpI4woLKv6biqIoc-g3brRYVrwZiLA130_provenance.